3B BlackBio Dx AGM 2026: ₹5 Dividend, FY26 PAT

Key development: AGM date and dividend proposal

3B BlackBio Dx Limited has scheduled its 54th Annual General Meeting (AGM) for September 29, 2026, at 11:30 am IST through video conferencing or other audio-visual means. The meeting is set to take up routine shareholder approvals, including the adoption of audited financial statements for the year ended March 31, 2026. A key item on the agenda is the final dividend for FY26. The board has recommended a final dividend of ₹5.00 per equity share, subject to shareholder approval. The company has also laid out the record date and e-voting window for shareholder participation. Separately, the company has disclosed that it held investor interactions where only public information was discussed.

FY26 consolidated performance snapshot

For FY26, 3B BlackBio Dx reported consolidated revenue from operations of ₹141.91 crore and a consolidated profit after tax (PAT) of ₹59.92 crore for the financial year ended March 31, 2026. These numbers were highlighted alongside the AGM announcement and dividend recommendation. The FY26 financial statements, both standalone and consolidated, are part of the “ordinary business” items proposed for adoption at the AGM. The board’s dividend recommendation is stated to be out of current profits and will require member approval at the meeting. The company’s communication also references the availability of its annual report through its website and the BSE website.

Dividend: amount, key dates, and reported yield

The recommended final dividend for FY26 is ₹5.00 per equity share. The company has indicated that shareholders on record as of September 22, 2026 will be eligible for dividend payout and voting rights. Market data included alongside the corporate action also referenced a dividend yield of 0.34% and noted “50% dividend” with an ex-date of September 22, 2026. The company’s formal AGM timeline also includes closure of the register of members and share transfer books for the AGM and dividend payment process. Shareholders typically use the record date to confirm eligibility for corporate actions such as dividends.

54th AGM: mode, timing, and participation mechanics

The AGM will be held virtually at 11:30 am IST on September 29, 2026. The company has provided remote e-voting in line with Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The cut-off date for determining eligibility to vote is Tuesday, September 22, 2026. Remote e-voting is scheduled to open on Saturday, September 26, 2026 at 9:00 am and close on Monday, September 28, 2026 at 5:00 pm IST. The register of members and share transfer books will remain closed from Wednesday, September 23, 2026 to Tuesday, September 29, 2026, both days inclusive.

Governance items on the agenda

Beyond adoption of accounts and the dividend resolution, the AGM notice outlines special business items linked to governance and audit compliance. One resolution covers the reappointment of Mrs. Mithla Dubey as a Non-Executive Director who is liable to retire by rotation. Another resolution seeks shareholder ratification of remuneration for the cost auditors. These matters are commonly presented at AGMs to ensure continuity in board composition and to complete statutory audit-related approvals.

Cost audit: proposed remuneration for FY27

The board is seeking ratification for remuneration of ₹50,000 payable to Sanjay Kasliwal & Associates for conducting the cost audit for the financial year ending March 31, 2027. This is listed as a specific proposal requiring member approval as part of the AGM’s special business. While the amount is relatively small in the context of overall financials, it is a formal compliance step for companies that fall within cost audit requirements. The approval also helps clarify the terms under which the cost audit engagement is carried out.

Access to annual report and shareholder communication

The company stated that shareholders who have not registered their email addresses will receive a notice directing them to access the Annual Report for FY 2025-26 through online sources. It indicated that the annual report can be accessed on the company’s website at www.kilpest.com under Investor Info > 3B BlackBio Dx Limited Annual Report 2026. The report is also available on the BSE website. The communication also urged shareholders to update KYC details and register email addresses to receive future communications.

Q1 FY27 numbers disclosed in results highlights

Separately from the FY26 annual numbers, the company’s consolidated highlights for Q1FY27 included quarterly operating and profitability metrics expressed in lakh rupees. Revenue from operations for Q1FY27 was ₹33.4908 crore, a 50.62% year-on-year increase versus ₹22.2346 crore in Q1FY26, and a 5.48% quarter-on-quarter decline versus ₹35.4341 crore in Q4FY26. Total income in Q1FY27 was ₹39.6338 crore, up 49.27% year-on-year from ₹26.5512 crore in Q1FY26, and down 13.05% quarter-on-quarter from ₹45.5829 crore in Q4FY26. Profit before tax for Q1FY27 was ₹13.2195 crore, down 16.67% year-on-year from ₹15.8635 crore in Q1FY26, and down 9.74% quarter-on-quarter from ₹14.6462 crore in Q4FY26. These quarterly figures were presented as a snapshot of recent operating performance.

Investor meetings: disclosures and compliance framing

The company also reported conducting a one-to-one investor meeting with Marcellus Investment Managers on September 16, 2026, reviewing information already disclosed through Q1-FY27 results and the investor presentation shared after the Q1 results announcement. The disclosure stated that no new material information was shared beyond what was already released, and that no unpublished price-sensitive information was discussed. A separate disclosure referenced the conclusion of a one-on-one virtual investor meeting with Param Capital on August 29, 2026, again stating that only public-domain information was discussed. Such disclosures are commonly made to document that investor interactions remain within regulatory norms on selective disclosure.

Market context and quoted trading references

Alongside the corporate updates, the stock was referenced at ₹1,564.50, down ₹20.30 (1.28%). Another quoted reference showed ₹1,619.30, up ₹34.50 (2.18%). A separate data line indicated ₹1,463.5 with a 7.29% one-year move, and a dividend yield figure of 0.34%. Broader market levels were also listed, including NIFTY at 23,329.00 (down 85.30 or 0.36%) and another index value at 74,529.08 (down 329.91 or 0.44%) at the time noted. These levels provide context for the trading environment around the corporate action timeline.

Key details at a glance

Q1FY27 comparison table (consolidated)

All figures below are as disclosed, converted from ₹ lakh to ₹ crore.

Market impact

The immediate market relevance of the announcement is concentrated around the dividend mechanics and the shareholder action calendar. The record date of September 22, 2026 and the AGM vote on September 29, 2026 set clear timelines for investors tracking eligibility and participation. The proposed dividend amount is explicitly stated at ₹5.00 per share, and the company has also provided the register closure period from September 23 to September 29, 2026. Separately, the latest disclosed quarterly trends show revenue growth year-on-year in Q1FY27, alongside declines in profit before tax compared with both Q1FY26 and Q4FY26. The investor meeting disclosures also matter from a compliance standpoint, as the company explicitly stated that no unpublished price-sensitive information was shared.

Analysis: why these disclosures matter

The AGM agenda combines financial approval items with governance resolutions, giving shareholders multiple decision points in one meeting cycle. Dividend declarations are typically a key trigger for retail participation, and the company has provided a complete schedule for remote e-voting, which is particularly important for a virtual AGM format. On the financial side, FY26 consolidated revenue and PAT figures frame the dividend recommendation in terms of reported annual performance. Meanwhile, the Q1FY27 snapshot provides a near-term view of operating scale and profitability trends, including a year-on-year rise in revenue from operations and a year-on-year decline in profit before tax. Finally, the one-to-one investor meeting disclosures add transparency by clarifying that discussions were limited to already-public information.

Conclusion

3B BlackBio Dx’s 54th AGM on September 29, 2026 is set to consider adoption of FY26 financial statements, approval of a ₹5.00 final dividend, and key governance and audit-related resolutions. The record date is September 22, 2026, with remote e-voting open from September 26 to September 28, 2026. Shareholders will look to the AGM outcome for final confirmation of the dividend and the approval of the director and cost audit items as set out in the notice.